Of note, insulin users, as active comparators, represented more advanced T2D patients (i.e., requiring intensive glycemic control), and thus confounding by indication in these selective patients cannot be ruled out; such confounding could mask the beneficial liver effect of GLP-1RAs [18]. Here, INS is linked to type 2 diabetes mellitus.